Skip to main content
Top
Published in: BMC Nephrology 1/2022

Open Access 01-12-2022 | Research

Vitamin D receptor gene polymorphism predicts left ventricular hypertrophy in maintenance hemodialysis

Authors: Bingman Liu, Qingqing Yang, Liangyu Zhao, Hua Shui, Xiaoyun Si

Published in: BMC Nephrology | Issue 1/2022

Login to get access

Abstract

Background

To verify that the single nucleotide polymorphisms (SNP) of vitamin D receptor (VDR) may lead to genetic susceptibility to left ventricular hypertrophy (LVH), the present study was designed to study four SNPs of VDR associated with LVH in maintenance hemodialysis (MHD) patients of Han nationality.

Methods

120 MHD patients were recruited at Department of Nephrology, Zhongnan Hospital of Wuhan University to analyze the expression of genotype, allele and haplotype of Fok I, Bsm I, Apa I and Taq I in blood samples, and to explore their correlation with blood biochemical indexes and ventricular remodeling.

Results

The results showed that the risks of CVD included gender, dialysis time, heart rate, SBP, glycated hemoglobin, calcium, iPTH and CRP concentration. Moreover, LAD, LVDd, LVDs, IVST and LVMI in B allele of Bsm I increased significantly. Fok I, Apa I and Taq I polymorphisms have no significant difference between MHD with LVH and without LVH. Further study showed that VDR expression level decreased significantly in MHD patients with LVH, and the B allele was positively correlated with VDR Expression.

Conclusion

VDR Bsm I gene polymorphism may predict cardiovascular disease risk of MDH patients, and provided theoretical basis for early detection and prevention of cardiovascular complications.
Literature
1.
go back to reference Kuragano T, Itoh K, Shimonaka Y, Kida A, Furuta M, Kitamura R, et al. Hepcidin as well as TNF-α are significant predictors of arterial stiffness in patients on maintenance hemodialysis. Nephrol Dial Transplant. 2011;26(8):2663–7.CrossRef Kuragano T, Itoh K, Shimonaka Y, Kida A, Furuta M, Kitamura R, et al. Hepcidin as well as TNF-α are significant predictors of arterial stiffness in patients on maintenance hemodialysis. Nephrol Dial Transplant. 2011;26(8):2663–7.CrossRef
3.
go back to reference Inoue K, Matsui I, Hamano T, Okuda K, Tsukamoto Y, Matsumoto A, et al. Maxacalcitol (22-Oxacalcitriol (OCT)) retards progression of left ventricular hypertrophy with renal dysfunction through inhibition of calcineurin-NFAT activity. Cardiovasc Drugs Ther. 2021;35(2):381–97.CrossRef Inoue K, Matsui I, Hamano T, Okuda K, Tsukamoto Y, Matsumoto A, et al. Maxacalcitol (22-Oxacalcitriol (OCT)) retards progression of left ventricular hypertrophy with renal dysfunction through inhibition of calcineurin-NFAT activity. Cardiovasc Drugs Ther. 2021;35(2):381–97.CrossRef
4.
go back to reference Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H, et al. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA. 2012;307(7):674–84.CrossRef Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H, et al. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA. 2012;307(7):674–84.CrossRef
5.
go back to reference Wang AY, Fang F, Chan J, Wen Y, Qing S, Chan IH, et al. Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial. J Am Soc Nephrol. 2014;25(1):175–86.CrossRef Wang AY, Fang F, Chan J, Wen Y, Qing S, Chan IH, et al. Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial. J Am Soc Nephrol. 2014;25(1):175–86.CrossRef
6.
go back to reference Thadhani R, Appelbaum E, Chang Y, Pritchett Y, Bhan I, Agarwal R, et al. Vitamin D receptor activation and left ventricular hypertrophy in advanced kidney disease. Am J Nephrol. 2011;33(2):139–49.CrossRef Thadhani R, Appelbaum E, Chang Y, Pritchett Y, Bhan I, Agarwal R, et al. Vitamin D receptor activation and left ventricular hypertrophy in advanced kidney disease. Am J Nephrol. 2011;33(2):139–49.CrossRef
7.
go back to reference Teitcher M, Weinerman S, Whybra C, Beck M, Sharon N, Elstein D, et al. Genetic polymorphisms of vitamin D receptor (VDR) in Fabry disease. Genetica. 2008;134(3):377–83.CrossRef Teitcher M, Weinerman S, Whybra C, Beck M, Sharon N, Elstein D, et al. Genetic polymorphisms of vitamin D receptor (VDR) in Fabry disease. Genetica. 2008;134(3):377–83.CrossRef
8.
go back to reference Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart. 2001;85(6):635–8.CrossRef Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart. 2001;85(6):635–8.CrossRef
9.
go back to reference Testa A, Mallamaci F, Benedetto FA, Pisano A, Tripepi G, Malatino L, et al. Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients. J Bone Miner Res. 2010;25(2):313–9.CrossRef Testa A, Mallamaci F, Benedetto FA, Pisano A, Tripepi G, Malatino L, et al. Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients. J Bone Miner Res. 2010;25(2):313–9.CrossRef
10.
go back to reference Nakhl S, Sleilaty G, Chouery E, Salem N, Chahine R, Farès N, et al. FokI vitamin D receptor gene polymorphism and serum 25-hydroxyvitamin D in patients with cardiovascular risk. Arch Med Sci Atheroscler Dis. 2019;4:e298–303.CrossRef Nakhl S, Sleilaty G, Chouery E, Salem N, Chahine R, Farès N, et al. FokI vitamin D receptor gene polymorphism and serum 25-hydroxyvitamin D in patients with cardiovascular risk. Arch Med Sci Atheroscler Dis. 2019;4:e298–303.CrossRef
11.
go back to reference Li L, Liu M, Kang L, Li Y, Dai Z, Wang B, et al. HHEX: A Crosstalker between HCMV Infection and Proliferation of VSMCs.Front Cell Infect Microbiol. 2016;6:169. Li L, Liu M, Kang L, Li Y, Dai Z, Wang B, et al. HHEX: A Crosstalker between HCMV Infection and Proliferation of VSMCs.Front Cell Infect Microbiol. 2016;6:169.
12.
14.
go back to reference Tripathi G, Sharma R, Sharma RK, Gupta SK, Sankhwar SN, Agrawal S. Vitamin D receptor genetic variants among patients with end-stage renal disease. Ren Fail. 2010;2(8):969077. Tripathi G, Sharma R, Sharma RK, Gupta SK, Sankhwar SN, Agrawal S. Vitamin D receptor genetic variants among patients with end-stage renal disease. Ren Fail. 2010;2(8):969077.
15.
go back to reference Shanker J, Maitra A, Arvind P Nair J Dash D Manchiganti R et al. A role of vitamin D levels and vitamin D receptor polymorphisms in relation to coronary artery disease: the Indian atherosclerosis research study. Coron Artery Dis. 2011;22: 324-332. Shanker J, Maitra A, Arvind P Nair J Dash D Manchiganti R et al. A role of vitamin D levels and vitamin D receptor polymorphisms in relation to coronary artery disease: the Indian atherosclerosis research study. Coron Artery Dis. 2011;22: 324-332.
16.
go back to reference Ozdemir FN, Sezer S, Atae B, Tutal E, Verdi H, Sahin F. et a1.Vitamin D receptor Bsm I and Tagl gene polymorphisms in a Turkish ESRD population: influences on parathyroid hormone response. Transplant Proc. 2005;37(7):2922–4.CrossRef Ozdemir FN, Sezer S, Atae B, Tutal E, Verdi H, Sahin F. et a1.Vitamin D receptor Bsm I and Tagl gene polymorphisms in a Turkish ESRD population: influences on parathyroid hormone response. Transplant Proc. 2005;37(7):2922–4.CrossRef
17.
go back to reference Nagaba Y, Heishi M, Tazawa H, Tsukamoto Y, Kobayashi Y. Vitamin D receptor gene polymorphisms affect secondary hyperparathyroidism in hemodialyzed patients. Am J Kidney Dis. 1998;32(3):464–9.CrossRef Nagaba Y, Heishi M, Tazawa H, Tsukamoto Y, Kobayashi Y. Vitamin D receptor gene polymorphisms affect secondary hyperparathyroidism in hemodialyzed patients. Am J Kidney Dis. 1998;32(3):464–9.CrossRef
18.
go back to reference Testa A, Mallamaei F, Benedetto FA, Pisano A, Tripepi G, Malatino L. et a1. Vitamin D receptor (VDR) gene polymorphism is associated with left ventrieular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients. J Bone Miner Res. 2010;25(2):313–9.CrossRef Testa A, Mallamaei F, Benedetto FA, Pisano A, Tripepi G, Malatino L. et a1. Vitamin D receptor (VDR) gene polymorphism is associated with left ventrieular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients. J Bone Miner Res. 2010;25(2):313–9.CrossRef
19.
go back to reference E1-Shehaby AM, E1-KhatibMM, Marzouk S, et al. Relationship of BsmI polymorphism of vitamin D receptor gene with left ventricular hypertrophy and atherosclemsis in hemodialysis patients. Scand J Clin Lab Invest. 2013; 73(1):75-81. E1-Shehaby AM, E1-KhatibMM, Marzouk S, et al. Relationship of BsmI polymorphism of vitamin D receptor gene with left ventricular hypertrophy and atherosclemsis in hemodialysis patients. Scand J Clin Lab Invest. 2013; 73(1):75-81.
20.
go back to reference Rubeno D, Giannini S, D’Angelo A, Battah AA. Secondary hyperparathyroidism is assiociated with vitamin D receptor polymorphism and bone density after renal transplantation. Biomed pharmacother. 2005;59(17):402–7. Rubeno D, Giannini S, D’Angelo A, Battah AA. Secondary hyperparathyroidism is assiociated with vitamin D receptor polymorphism and bone density after renal transplantation. Biomed pharmacother. 2005;59(17):402–7.
21.
go back to reference Santos BR, Casanova G, Silva TR, Marchesan LB, Oppermann K, Spritzer PM. Are vitamin D deficiency and VDR gene polymorphisms associated with high blood pressure as defined by the ACC/AHA 2017 criteria in postmenopausal women? Maturitas. 2021;149:26–33.CrossRef Santos BR, Casanova G, Silva TR, Marchesan LB, Oppermann K, Spritzer PM. Are vitamin D deficiency and VDR gene polymorphisms associated with high blood pressure as defined by the ACC/AHA 2017 criteria in postmenopausal women? Maturitas. 2021;149:26–33.CrossRef
22.
go back to reference Al-Daghri NM, Mohammed AK, Al-Attas OS, Ansari MGA, Wani K, Hussain SD, et al. Vitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients. Sci Rep. 2017;7(1):8280.CrossRef Al-Daghri NM, Mohammed AK, Al-Attas OS, Ansari MGA, Wani K, Hussain SD, et al. Vitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients. Sci Rep. 2017;7(1):8280.CrossRef
23.
go back to reference Puttachandra Prabhakar P, Majumdar V, Kulkarni GB, Christopher R. Genetic variants of vitamin D receptor and susceptibility to ischemic stroke. Biochem Biophys Res Commun. 2015;456(2):631–6. Puttachandra Prabhakar P, Majumdar V, Kulkarni GB, Christopher R. Genetic variants of vitamin D receptor and susceptibility to ischemic stroke. Biochem Biophys Res Commun. 2015;456(2):631–6.
24.
go back to reference Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, et al. Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Circulation. 2015;132(1):27–39.CrossRef Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, et al. Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Circulation. 2015;132(1):27–39.CrossRef
25.
go back to reference Wolf M, Block GA, Chertow GM, Cooper K, Fouqueray B, Moe SM, et al. Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis.Clin Kidney J. 2019;13(1):75–84. Wolf M, Block GA, Chertow GM, Cooper K, Fouqueray B, Moe SM, et al. Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis.Clin Kidney J. 2019;13(1):75–84.
26.
go back to reference Dörr K, Kammer M, Reindl-Schwaighofer R, Lorenz M, Prikoszovich T, Marculescu R, et al. Randomized Trial of Etelcalcetide for Cardiac Hypertrophy in Hemodialysis. Circ Res. 2021;128(11):1616–25.CrossRef Dörr K, Kammer M, Reindl-Schwaighofer R, Lorenz M, Prikoszovich T, Marculescu R, et al. Randomized Trial of Etelcalcetide for Cardiac Hypertrophy in Hemodialysis. Circ Res. 2021;128(11):1616–25.CrossRef
27.
go back to reference Stephen AS, Stuart MS, Akhtar A, Martin P, Charles WB. Rationale for raising current clinical practice guideline target for serum 25-hydroxyvitamin D in chronic kidney disease. Am J Nephrol. 2019;49(4):284–93.CrossRef Stephen AS, Stuart MS, Akhtar A, Martin P, Charles WB. Rationale for raising current clinical practice guideline target for serum 25-hydroxyvitamin D in chronic kidney disease. Am J Nephrol. 2019;49(4):284–93.CrossRef
28.
go back to reference Milovanova LY, Taranova MV, Milovanova SY, Kozlovskaya Lysenko LV, Pasechnik AI, et al. Cardiovascular remodeling as a result of fibroblast growth factor-23 (FGF-23)/Klotho imbalance in patients with CKD. Int Urol Nephrol. 2021. https://doi.org/10.1007/s11255-021-03046-8. Milovanova LY, Taranova MV, Milovanova SY, Kozlovskaya Lysenko LV, Pasechnik AI, et al. Cardiovascular remodeling as a result of fibroblast growth factor-23 (FGF-23)/Klotho imbalance in patients with CKD. Int Urol Nephrol. 2021. https://​doi.​org/​10.​1007/​s11255-021-03046-8
29.
go back to reference Freitas AT, Calhau C, Antunes G, et al. Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity. Sci Rep. 2021;11(1):20837.CrossRef Freitas AT, Calhau C, Antunes G, et al. Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity. Sci Rep. 2021;11(1):20837.CrossRef
30.
go back to reference Peršić V, Raljević D, Markova-Car E, Cindrić L, Miškulin R, Žuvić M, et al. Vitamin D-binding protein (rs4588) T/T genotype is associated with anteroseptal myocardial infarction in coronary artery disease patients. Ann Transl Med. 2019;7(16):374.CrossRef Peršić V, Raljević D, Markova-Car E, Cindrić L, Miškulin R, Žuvić M, et al. Vitamin D-binding protein (rs4588) T/T genotype is associated with anteroseptal myocardial infarction in coronary artery disease patients. Ann Transl Med. 2019;7(16):374.CrossRef
31.
go back to reference Sedky NK, Hassanein SI, Gad MZ. Independent assortment of GC gene polymorphism (rs2282679) and 25-hydroxyvitamin D levels in coronary artery disease. Can J Physiol Pharmacol. 2018;96(4):345–51.CrossRef Sedky NK, Hassanein SI, Gad MZ. Independent assortment of GC gene polymorphism (rs2282679) and 25-hydroxyvitamin D levels in coronary artery disease. Can J Physiol Pharmacol. 2018;96(4):345–51.CrossRef
32.
go back to reference Daffara V, Verdoia M, Rolla R, Nardin M, Marino P, Bellomo G, et al. Impact of polymorphism rs7041 and rs4588 of Vitamin D Binding Protein on the extent of coronary artery disease. Nutr Metab Cardiovasc Dis. 2017;27(9):775–83.CrossRef Daffara V, Verdoia M, Rolla R, Nardin M, Marino P, Bellomo G, et al. Impact of polymorphism rs7041 and rs4588 of Vitamin D Binding Protein on the extent of coronary artery disease. Nutr Metab Cardiovasc Dis. 2017;27(9):775–83.CrossRef
Metadata
Title
Vitamin D receptor gene polymorphism predicts left ventricular hypertrophy in maintenance hemodialysis
Authors
Bingman Liu
Qingqing Yang
Liangyu Zhao
Hua Shui
Xiaoyun Si
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2022
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-021-02640-3

Other articles of this Issue 1/2022

BMC Nephrology 1/2022 Go to the issue